Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.92 USD | +9.25% | +14.56% | +15.87% |
Mar. 28 | North American Morning Briefing : Stocks Set for -2- | DJ |
Jan. 30 | North American Morning Briefing : Microsoft Kicks Off Big Tech Bonanza | DJ |
Chart calendar Cidara Therapeutics, Inc.
Upcoming events on Cidara Therapeutics, Inc.
Past events on Cidara Therapeutics, Inc.
2024-02-27 | Q4 2023 Earnings Release (Projected) |
2023-12-07 06:00 am | European Society for Medical Oncology Immuno Oncology Congress - Discovery of a Novel, Dual CD73 & P |
2023-12-07 06:00 am | European Society for Medical Oncology Immuno Oncology Congress - Discovery of CBO421, a First-in-Cla |
2023-11-03 03:00 pm | Society for Immunotherapy of Cancer Meeting |
2023-11-02 04:15 pm | Q3 2023 Earnings Release |
2023-10-14 12:15 pm | IDWeek Conference - James Levin |
2023-10-14 12:15 pm | IDWeek Conference - Shawn Flanagan |
2023-10-14 10:30 am | IDWeek Conference - James Levin |
2023-09-21 12:00 pm | R&D Day |
2023-09-11 10:00 am | H.C. Wainwright Global Investment Conference |
2023-08-03 04:08 pm | Q2 2023 Earnings Release |
2023-06-22 11:00 am | Annual General Meeting |
2023-06-22 09:30 am | Adenosine Pathway Targeted Cancer Immunotherapy Summit |
2023-05-11 04:37 pm | Q1 2023 Earnings Release |
2023-05-04 02:35 pm | International Society for Influenza and Respiratory Virus Diseases Conference |
2023-05-03 05:30 pm | International Society for Influenza and Respiratory Virus Diseases Conference |
2023-04-17 12:45 pm | Needham Healthcare Conference |
2023-04-03 11:00 am | Cantor The Future of Oncology Virtual Symposium - Panel |
2023-03-23 07:12 am | Q4 2022 Earnings Release |
2023-03-06 11:35 am | ESMO Targeted Anticancer Therapies Congress - Presentation Number: 45P |
Annual results
Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 20,9 17,1 22.67% | 12,1 18,5 -34.89% | 49,6 46,6 6.28% | 64,3 64,7 -0.62% | 57,8 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -63,3 -63,7 0.58% | -41,7 -47,4 11.9% | -71,8 -60,9 -17.92% | -42,3 -47,1 10.21% | -29,7 -28,4 -4.82% | -28,1 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -59,0 -67,0 11.87% | -41,1 -41,9 2.04% | -72,1 -61,1 -18.06% | -42,5 -47,5 10.66% | -29,5 -28,3 -4.37% | -26,3 |
Net income Million USD | Released Forecast Spread | -69,3 -70,4 1.54% | -41,1 -42,1 2.42% | -74,9 -62,4 -19.9% | -42,5 -47,9 11.39% | -29,8 -30,4 1.82% | -27,4 |
EPS USD | Released Forecast Spread | -2,76 -2,96 6.66% | -1,41 -1,38 -1.84% | -1,80 -1,55 -16.5% | -0,81 -0,88 8.3% | -0,43 -0,42 -3.2% | -0,31 |
Announcement Date | 28/02/19 | 04/03/20 | 25/02/21 | 07/03/22 | 23/03/23 | - |
Quarterly results
Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 7,08 2,94 140.5% | 7,23 4,31 67.62% | 7,11 4,71 50.86% | 6,22 4,97 25.2% | 40,7 22,7 79.67% | 10,2 10,6 -3.29% | 26,0 18,7 39.11% | 7,61 11,5 -34.06% | 12,7 8,14 56.25% | 11,5 | 13,1 | 6,95 | 4,20 | 5,71 |
EBIT Million USD | Released Forecast Spread | -18,0 -20,0 9.84% | -16,8 -21,6 22.25% | -18,3 -19,2 4.75% | -13,1 -19,3 32.06% | 14,9 5,83 156.13% | -13,3 -11,9 -11.49% | 2,98 -3,28 190.67% | -12,8 -12,4 -3.31% | -8,56 -15,2 43.68% | -9,86 | -6,85 | -12,8 | -16,0 | -14,3 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -18,1 -20,0 9.54% | -16,8 -21,6 22.06% | -18,3 -19,2 4.83% | -13,1 -19,2 31.73% | 15,0 5,81 157.63% | -13,1 -11,9 -10.28% | 3,21 -3,13 202.42% | -12,2 -12,3 0.51% | -7,94 -13,6 41.51% | -9,53 | -6,60 | -12,6 | -15,8 | -14,1 |
Net income Million USD | Released Forecast Spread | -18,1 -20,0 9.54% | -16,8 -21,6 22.06% | -18,3 -19,2 4.83% | -13,1 -19,3 32.18% | 11,9 5,81 104.64% | -13,4 -11,9 -12.57% | 2,53 -3,13 180.81% | -12,4 -12,3 -0.71% | -8,17 -13,6 39.81% | -9,53 | -6,60 | -12,6 | -15,8 | -14,1 |
EPS USD | Released Forecast Spread | -0,37 -0,35 -4.52% | -0,28 -0,33 13.85% | -0,27 -0,28 2.88% | -0,19 -0,28 32.14% | 0,17 0,07 151.85% | -0,19 -0,15 -29.54% | 0,03 -0,04 181.81% | -0,14 -0,13 -7.69% | -0,09 -0,15 40% | -0,10 | -0,07 | -0,14 | -0,16 | -0,14 |
Announcement Date | 10/11/21 | 07/03/22 | 11/05/22 | 09/08/22 | 03/11/22 | 23/03/23 | 11/05/23 | 03/08/23 | 02/11/23 | - | - | - | - | - |
Past sector events for Cidara Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock
- Equities
- Stock Cidara Therapeutics, Inc. - Nasdaq
- Calendar Cidara Therapeutics, Inc.